Penicillin: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 1: Line 1:
 
==Background==
 
==Background==
   
=== Nomenclature ===
+
===Nomenclature===
   
* Broadly speaking, formulations of penicillin G are soluble and used for IV or IM administration, and penicillin V is used for oral administration but does not achieve high levels in the serum
+
*Broadly speaking, formulations of penicillin G are soluble and used for IV or IM administration, and penicillin V is used for oral administration but does not achieve high levels in the serum
   
 
{| class="wikitable"
 
{| class="wikitable"
Line 33: Line 33:
 
*Directly inhibits [[Penicillin-binding protein|penicillin-binding proteins]]
 
*Directly inhibits [[Penicillin-binding protein|penicillin-binding proteins]]
   
=== Spectrum of Activity ===
+
===Spectrum of Activity===
   
* Generally active against Gram-positive cocci, especially [[streptococci]] but some strains of [[Staphylococcus aureus]], most [[clostridia]], [[Neisseria species]], and some [[Haemophilus influenzae]]
+
*Generally active against Gram-positive cocci, especially [[streptococci]] but some strains of [[Staphylococcus aureus]], most [[clostridia]], [[Neisseria species]], and some [[Haemophilus influenzae]]
* Not active against aerobic Gram-negative bacilli
+
*Not active against aerobic Gram-negative bacilli
* Penicillin G is generally more active than penicillin V across all bacteria
+
*Penicillin G is generally more active than penicillin V across all bacteria
   
=== Clinical Breakpoints ===
+
===Clinical Breakpoints===
 
{| class="wikitable"
 
{| class="wikitable"
 
! rowspan="2" |Species
 
! rowspan="2" |Species
Line 140: Line 140:
 
|
 
|
 
|}
 
|}
  +
  +
== Safety ==
  +
  +
=== Adverse Events ===
  +
  +
==== Hypersensitivity Reactions ====
  +
  +
* Can cause any type of [[hypersensitivity reaction]] (I to IV)
  +
* Type I: [[anaphylaxis]] and [[urticaria]]
  +
* Type II: [[autoimmune hemolytic anemia]]
  +
* Type III: [[serum sickness-like reaction]]
  +
* Type IV:
  +
** Delayed maculopapular drug rash
  +
*** Usually after 7 to 10 days of starting and up to 1 to 3 days after stopping)
  +
*** Progresses over days, with lesions that are relatively fixed
  +
*** Can worsen over a few days after stopping, then resolves over 1 to 2 weeks
  +
*** Pruritis is variable
  +
*** Most commonly occur in the context of a viral infection
  +
** [[Contact dermatitis]]
  +
 
[[Category:Beta-lactams]]
 
[[Category:Beta-lactams]]

Revision as of 14:21, 25 February 2021

Background

Nomenclature

  • Broadly speaking, formulations of penicillin G are soluble and used for IV or IM administration, and penicillin V is used for oral administration but does not achieve high levels in the serum
Formulation Other Names Comments
sodium penicillin G sodium benzylpenicillin

crystalline penicillin

soluble, used for IV
procaine penicillin G procaine benzylpenicillin

procaine penicilli

less soluble, used for IM
benzathine penicillin G DBED penicillin less soluble than procaine, used for IM
penicillin V phenoxymethylpenicillin used for PO, but poor absorption

Mechanism of Action

Spectrum of Activity

Clinical Breakpoints

Species Breakpoints (μg/mL) Breakpoints (mm)
S I R S I R
Anaerobes except Bacteroides ≤0.5 1 ≥2
Enterococcus species ≤8 ≥16 ≥15 ≤14
Neisseria gonorrhoeae ≤0.06 0.12-1 ≥2 ≥47 27-46 ≤26
Neisseria meningitidis ≤0.06 0.12-0.25 ≥0.5
Staphylococcus species ≤0.12 ≥0.25 ≥29 ≤28
Streptococcus pneumoniae ≥20
Streptococcus pneumoniae IV (nonmeningitis) ≤2 4 ≥8
Streptococcus pneumoniae IV (meningitis) ≤0.06 ≥0.12
Streptococcus pneumoniae PO (pen V) ≤0.06 0.12-1 ≥2
Streptococcus species (β-hemolytic) ≤0.12 ≥24
Streptococcus species (viridans group) ≤0.12 0.25-2 ≥4

Safety

Adverse Events

Hypersensitivity Reactions